Poster #2: A dual 6-month & 18-month prospective, randomized, placebo-controlled, double-blind, pivotal clinical trial investigating efficacy and safety of buntanetap in early Alzheimer's patients.

BOSTON, July 08, 2025 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced it will deliver ...

The RSC Nucleic Acids Group invites you to their Forum meeting, which will take place in-person at the RSC's iconic Burlington House in London. This is the NAG’s annual meeting, bringing together the ...

Publish a journal article From finding the right journal to maximising the impact of your work, we're with you every step of the way.